Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLSN

Imunon (CLSN) Stock Price, News & Analysis

Imunon logo

About Imunon Stock (NASDAQ:CLSN)

Key Stats

Today's Range
N/A
50-Day Range
$1.95
$2.63
52-Week Range
N/A
Volume
711 shs
Average Volume
150,471 shs
Market Capitalization
$13.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLSN Stock News Headlines

Imunon Inc IMNN
CLSN.L Regulatory News
Forget AI, This Will Be the Next Big Tech Breakthrough
After picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge...tc pixel
See More Headlines

CLSN Stock Analysis - Frequently Asked Questions

Imunon, Inc. (NASDAQ:CLSN) announced its earnings results on Monday, August, 15th. The biotechnology company reported ($0.87) earnings per share for the quarter, beating the consensus estimate of ($1.12) by $0.25. Imunon had a negative trailing twelve-month return on equity of 50.18% and a negative net margin of 5,229.80%.

Imunon's stock reverse split before market open on Tuesday, March 1st 2022.The 1-15 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imunon investors own include Tonix Pharmaceuticals (TNXP), Tesla (TSLA), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Acasti Pharma (ACST), Corbus Pharmaceuticals (CRBP) and Dynavax Technologies (DVAX).

Company Calendar

Last Earnings
8/15/2022
Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CLSN
CIK
749647
Employees
27
Year Founded
1982

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.77 million
Net Margins
-5,229.80%
Pretax Margin
-5,506.60%
Return on Equity
-50.18%
Return on Assets
-36.94%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
6.52
Quick Ratio
6.52

Sales & Book Value

Annual Sales
$500 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.66 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,099,000
Free Float
6,768,000
Market Cap
$13.91 million
Optionable
Optionable
Beta
2.27

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CLSN) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners